Fidelity Investments
TYRA icon

Fidelity Investments’s Tyra Biosciences TYRA Stock Holding History

Fidelity Investments’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285M Buy
8,920,513
+1,172,865
+15% +$38.8M 0.01% 782
2026
Q1 		$297M Buy
7,747,648
+7,735,085
+61,570% +$250M 0.02% 694
2025
Q4 		$330K Buy
12,563
+34
+0.3% +$624 ﹤0.01% 3234
2025
Q3 		$175K Buy
12,529
+327
+3% +$3.73K ﹤0.01% 3407
2025
Q2 		$117K Sell
12,202
-1,694,946
-99% -$16.1M ﹤0.01% 3549
2025
Q1 		$15.9M Sell
1,707,148
-1,400,822
-45% -$18.1M ﹤0.01% 1754
2024
Q4 		$43.2M Sell
3,107,970
-264,880
-8% -$4.81M ﹤0.01% 1438
2024
Q3 		$79.3M Buy
3,372,850
+26,187
+0.8% +$550K ﹤0.01% 1193
2024
Q2 		$53.5M Sell
3,346,663
-630,545
-16% -$10.9M ﹤0.01% 1292
2024
Q1 		$65.2M Buy
3,977,208
+1,208,512
+44% +$19.8M ﹤0.01% 1217
2023
Q4 		$38.3M Sell
2,768,696
-1,130,131
-29% -$14.6M ﹤0.01% 1392
2023
Q3 		$53.7M Sell
3,898,827
-218,042
-5% -$3.23M ﹤0.01% 1216
2023
Q2 		$70.1M Buy
4,116,869
+968,882
+31% +$14.1M 0.01% 1141
2023
Q1 		$50.6M Sell
3,147,987
-731,136
-19% -$8.7M ﹤0.01% 1260
2022
Q4 		$29.5M Sell
3,879,123
-147,178
-4% -$1.04M ﹤0.01% 1467
2022
Q3 		$35.4M Buy
4,026,301
+58,211
+1% +$532K ﹤0.01% 1382
2022
Q2 		$28.4M Sell
3,968,090
-121,995
-3% -$971K ﹤0.01% 1509
2022
Q1 		$43.8M Buy
4,090,085
+621,254
+18% +$7.37M ﹤0.01% 1451
2021
Q4 		$48.8M Buy
3,468,831
+1,560,172
+82% +$31M ﹤0.01% 1429
2021
Q3 		$33.6M Buy
+1,908,659
New +$36.5M ﹤0.01% 1599

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Fidelity Investments's TYRA Position: Q2 2026 in Review

Fidelity Investments increased its Tyra Biosciences (TYRA) stake by 15% in Q2 2026, buying an estimated $38.8M and bringing the position to 8,920,513 shares worth $285M. The position accounts for 0.01% of the portfolio, ranked #782.

Fidelity Investments first reported a position in TYRA in Q3 2021 and has held it in 20 quarters since. The position peaked at $297M in Q1 2026. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Fidelity Investments held 8,920,513 shares of Tyra Biosciences worth $285M as of Q2 2026.
  • Fidelity Investments bought 1,172,865 Tyra Biosciences shares in Q2 2026, an estimated $38.8M.
  • Tyra Biosciences made up 0.01% of Fidelity Investments's portfolio in Q2 2026, its #782 holding.
  • Fidelity Investments first reported a position in Tyra Biosciences in Q3 2021 and has held it in 20 quarters since.
  • Fidelity Investments's Tyra Biosciences position peaked at $297M in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.